Andere Sprachen InnoCan Pharma Corporation

Aktien

A41FTP

CA45783P5085

INNO

Pharmazeutika

Markt geschlossen - Canadian Securities Exchange Andere Börsenplätze 20:29:13 13.01.2026			% 5 Tage	Veränd. 1. Jan.
8.100 ^CAD	-5.37%		+1.12%	+20.90%

02.01.	InnoCan Pharma wird ab nächster Woche an der NYSE American gelistet	MT
10.12.	InnoCan gibt öffentliche Einreichung der geänderten Registrierungserklärung für geplantes US-Angebot bekannt	MT

Andere Sprachen

02.01.	InnoCan Pharma to List on NYSE American Next Week
02.01.	Innocan Pharma Corp Brief: Anticipates Listing on NYSE American Stock Exchange with Concurrent Offering
10.12.	InnoCan Announces Public Filing of Amended Registration Statement For Proposed U.S. Offering
10.12.	Innocan Pharma Announces Public Filing of Amended Registration Statement for Proposed U.S. Public Offering
27.11.	Innocan Pharma Nine-month Operating Loss Stable, Revenue Fall 10%
27.11.	Innocan Pharma Reports Financial Results for Q3 2025, with Revenues at US $21.6M
26.11.	InnoCan Pharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
26.11.	InnoCan Pharma : Financial Statements as of September 30, 2025
26.11.	InnoCan Pharma : MD&A Report For Nine Months Period Ended September 30, 2025
24.11.	Innocan Pharma Corporation Announces Promising Translational Evidence from A Pain Relief Study of Repeated Lpt-Cbd Administration in Goats
24.11.	Innocan Pharma Announces Promising Translational Evidence from a Pain Relief Study of Repeated LPT-CBD Administration in Goats
20.11.	Innocan Pharma announces promising results of LPT-CBD administered to Gottingen Minipigs, a well-known drug toxicology model
24.10.25	Innocan Pharma to Present at the 2025 ThinkEquity Conference
15.10.25	Innocan Pharma Corporation Announces Its Patent for Lpt-Cbd Is Allowed in Japan
15.10.25	Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan
18.09.25	Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection
18.09.25	Innocan Pharma Corporation Partners with Freedom Farm to Bring Remedy and Hope with its LPT-CBD Injection
15.09.25	Innocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference
02.09.25	CSE Bulletin: Consolidation - InnoCan Pharma Corporation (INNO)
29.08.25	InnoCan Pharma Plans One-for-65 Share Consolidation Ahead of Nasdaq Listing
29.08.25	Innocan Pharma announces details of proposed share consolidation
29.08.25	Innocan Pharma Announces Details of Proposed Share Consolidation
28.08.25	InnoCan Pharma : MD&A Report For Six Months Period Ended June 30, 2025
28.08.25	InnoCan Pharma : Financial Statements as of June 30, 2025
27.08.25	InnoCan Pharma Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen MarketScreener Artikel MarketScreener Analysen Trading-Ideen

Andere Sprachen InnoCan Pharma Corporation

Aktien

A41FTP

CA45783P5085

INNO

Pharmazeutika

Andere Sprachen

Filter